Activation of NF-kappa B by the dsRNA-dependent protein kinase, PKR involves the I kappa B kinase complex

J Gil1, J Alcamí, M Esteban

  • 1Department of Molecular and Cellular Biology, Centro Nacional de Biotecnología, Consejo Superior de Investigaciones Científicas, (CSIC), Campus Universidad Autónoma, 28049 Madrid, Spain.

Oncogene
|March 21, 2000
PubMed

Insights

The double-stranded RNA-dependent protein kinase (PKR) activates the NF-kappa B pathway by interacting with the IKK complex. This mechanism is crucial for PKR

Area of Science:

  • Molecular Biology
  • Immunology
  • Virology

Background:

  • The double-stranded RNA-dependent protein kinase (PKR) is known for translational control.
  • PKR also acts as a transcriptional regulator with antiviral and antitumoural roles.
  • PKR-induced NF-kappa B activation is linked to apoptosis.

Purpose of the Study:

  • To elucidate the mechanism by which PKR mediates NF-kappa B activation upon double-stranded RNA (dsRNA) exposure.
  • To identify the specific NF-kappa B complexes and upstream signaling components involved.

Main Methods:

  • Utilized vaccinia virus (VV) recombinants expressing PKR.
  • Induced endogenous PKR with poly I:C (pIC) treatment.
  • Employed gel shift assays, luciferase reporter assays, and immunoprecipitation.

Main Results:

  • PKR-induced NF-kappa B complexes primarily consist of p50-p65 and c-rel-p50 heterodimers.
  • PKR phosphorylates I kappa B alpha at serine 32, leading to its degradation.
  • PKR interacts with the IKK complex (IKK1/IKK2), and dominant-negative mutants inhibit NF-kappa B activation.

Conclusions:

  • PKR activates the NF-kappa B pathway through the I kappa B kinase (IKK) complex.
  • This activation mechanism is a key physiological function of PKR.
  • Understanding this pathway is vital for antiviral and antitumoural strategies.

Related Concept Videos

Co-activators and Co-repressors02:04

Co-activators and Co-repressors

Gene transcription is regulated by the synergistic action of several proteins that form a complex at a gene regulatory site. This is observed in eukaryotes, where the regulation of gene expression is a complex process. Regulatory proteins in eukaryotes can broadly be classified into two types – regulators that bind directly to specific DNA sequences and co-regulators that associate with regulatory proteins but cannot directly bind to the DNA. These co-regulators are further divided into...
NF-κB-dependent Signaling Pathway02:26

NF-κB-dependent Signaling Pathway

The transcription factor NF-κB was discovered in 1986 in the lab of Nobel laureate Professor David Baltimore, for its interaction with the immunoglobulin light chain enhancer in B-cells. After more than three decades of study, it is now evident that NF-κB regulates the expression of over 100 genes. Most of these genes play an essential role in the innate and adaptive immune responses as well as the inflammatory responses of animals.
NF-κB-dependent Signaling Mechanism
The heterodimer of NF-κB...
Regulation of the Unfolded Protein Response01:31

Regulation of the Unfolded Protein Response

Inositol-requiring kinase one or IRE1 is the most conserved eukaryotic unfolded protein response (UPR) receptor. It is a type I transmembrane protein kinase receptor with a distinctive site-specific RNase activity. As the binding mechanics of the misfolded proteins with the N-terminal domain of IRE-1 are unclear, three binding models — direct, indirect, and allosteric -- are proposed for receptor activation. Nevertheless, it is known that once a misfolded protein associates with IRE1, it...
MAPK Signaling Cascades01:07

MAPK Signaling Cascades

Mitogen-activated protein kinase, or MAPK pathway, activates three sequential kinases to regulate cellular responses such as proliferation, differentiation, survival, and apoptosis. The canonical MAPK pathway starts with a mitogen or growth factor binding to an RTK. The activated RTKs stimulate Ras, which recruits Raf or MAP3 Kinase (MAPKKK), the first kinase of the MAPK signaling cascade. Raf further phosphorylates and activates MEK or MAP2 Kinases (MAPKK), which in turn phosphorylates MAP...
The JAK-STAT Signaling Pathway01:20

The JAK-STAT Signaling Pathway

Several cytokine receptors have tightly bound Janus kinase or JAK proteins attached at their cytosolic tail. Small signaling molecules such as cytokines, growth hormones, or prolactins bind to the cytokine receptors and initiate their dimerization. The dimerization brings the cytosolic JAKs together that trans-phosphorylate and activates each other. The activated JAKs now phosphorylate cytosolic tails of the cytokine receptors, which serve as binding sites for adaptor proteins such as  SH2...
PI3K/mTOR/AKT Signaling Pathway01:22

PI3K/mTOR/AKT Signaling Pathway

The mammalian target of rapamycin  (mTOR) is a serine/threonine kinase that regulates growth, proliferation, and cell survival in response to hormones, growth factors, or nutrient availability. This kinase exists in two structurally and functionally distinct forms: mTOR complex 1  (mTORC1) and mTOR complex 2  (mTORC2). The first form (mTORC1) is composed of a rapamycin-sensitive Raptor and proline-rich Akt substrate, PRAS40. In contrast,  mTORC2 consists of a rapamycin-insensitive companion...